A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment

Clinical trial NCT04563026 · COMPLETED

Trial details

NCT number: NCT04563026
Sponsor: Durect
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alcoholic Hepatitis

Start date: 2021-01-22
Primary completion: 2023-09-06
Enrollment: 307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.